Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Note 1 - Reporting Entity (Details Textual)

v3.8.0.1
Note 1 - Reporting Entity (Details Textual)
Dec. 27, 2017
Dec. 26, 2017
Neptune Technologies and Bioressources Inc. [member] | Acasti Pharma Inc. [member]    
Statement Line Items [Line Items]    
Proportion of ownership interest in associate 19.80% 34.00%